Skip to content

Clinical trials

Completed Observational Hyperphosphatemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperphosphatemia Phase: Observational Status: Completed Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20092
20102
20111
20121
20132
20161
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer3
Shire2
Astellas Pharma Inc1
Fresenius Medical Care Deutschland GmbH1
Genzyme, a Sanofi Company1
Keryx Biopharmaceuticals1
King Faisal Specialist Hospital & Research Center1
Shiraz University of Medical Sciences1
Vifor Fresenius Medical Care Renal Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperphosphatemia12
Kidney Failure, Chronic2
Renal Insufficiency, Chronic2
Diabetes Mellitus1
Hypercalcemia1
Hyperkalemia1
Hyperphagia1
Kidney Diseases1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.